IIF

Vaxxas Announces Appointment of Dan Devine as Chief Business Officer and General Counsel

Retrieved on: 
Wednesday, April 13, 2022
Oncology, Health, Infectious Diseases, Clinical Trials, Pharmaceutical, Biotechnology, IIF, Patri Friedman, Biotechnology, Dan, COVID-19, Refrigeration, Time, NASDAQ, Transport, Wall Street, General counsel, Biomedical Advanced Research and Development Authority, Infection, Growth, Efficiency, Vaccination, University, Development, Vaccine, Skin, Temperature, Innovation, Australian Securities Exchange, Safety, BARDA, Multimedia, Industry, Pharmaceutical industry, Fine chemical, Pfizer, Mesoblast

Dan Devine joins the company as Chief Business Officer and General Counsel.

Key Points: 
  • Dan Devine joins the company as Chief Business Officer and General Counsel.
  • Over his career, Dan has led or supported the negotiation of over 50 M&A, licensing, financing, and other business development collaborations.
  • "Im very excited to join Vaxxas at this critical juncture, and I look forward to helping David and the rest of our team achieve our ambitious growth goals, said Dan Devine, Chief Business Officer and General Counsel of Vaxxas.
  • As Chief Business Officer and General Counsel, Dan will report directly to Vaxxas CEO David Hoey and has been appointed as Executive Vice President.

Vaxxas Licenses HexaPro Spike Glycoprotein from University of Texas at Austin for Use on its Needle-Free Vaccine Patches

Retrieved on: 
Wednesday, March 23, 2022
Biotechnology, Infectious Diseases, Health, Pharmaceutical, Clinical Trials, IIF, Temperature, Vaccination, Trial of the century, Refrigeration, Organic acid, Transport, University, Coronavirus, Skin, Vaccine, MacLellan, Cockrell School of Engineering, Biotechnology, Globe, Severe acute respiratory syndrome coronavirus 2, CEO, Omicron, United, Science Advances, Innovation, Immune system, University of Sydney School of Molecular Bioscience, BARDA, Safety, NIH, Infection, UT, COVID-19, Biomedical Advanced Research and Development Authority, Department, Development, Efficiency, Moses Austin, Pharmaceutical industry, University of Texas at Austin, Chemistry, Science, SPIKE PROTEINS AND HEXAPRO, VAXXAS’ HD-MAP TECHNOLOGY, VAXXAS

Vaxxas , a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, today announced that The University of Texas at Austin has granted Vaxxas an exclusive license to a next-generation SARS-CoV-2 spike subunit vaccine (HexaPro), for vaccination using a patch.

Key Points: 
  • Vaxxas , a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, today announced that The University of Texas at Austin has granted Vaxxas an exclusive license to a next-generation SARS-CoV-2 spike subunit vaccine (HexaPro), for vaccination using a patch.
  • We can now rapidly advance our clinical trials with our next-generation COVID-19 vaccine patch.
  • Vaxxas plans to complete a Phase 1 clinical study of its proprietary HexaPro/HD-MAP COVID-19 vaccine this year.
  • "The current pandemic has underscored the lifesaving potential of innovative technologies, and we think novel vaccination approaches clearly offer unique benefits.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intricon Corporation (Nasdaq - IIN), Inc., South Jersey Industries, Inc. (NYSE - SJI), Tower Semiconductor (Nasdaq - TSEM), Preferred Apartment Communities, Inc. (NYS

Retrieved on: 
Friday, March 4, 2022
Intel, Kerala Infrastructure Investment Fund Board, The Lord of the Rings: The Two Towers (board game), LLC, Company, IIF, SJI, INTC, Nasdaq, Brodsky, GLOBE, Security (finance), Property management

If you own shares and wish to discuss the investigation, contact Jason Brodsky or Marc Ackerman at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky or Marc Ackerman at 855-576-4847.
  • Under the terms of the agreement, Intricon will be acquired by an affiliate of Altaris Capital Partners, LLC (collectively with its affiliates, Altaris).
  • Intricon shareholders will receive $24.25 in cash for each share of Intricon stock they hold.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Universal Security Instruments, Inc. (NYSE American - UUU), South Jersey Industries, Inc. (NYSE - SJI), Tower Semiconductor (Nasdaq - TSEM), Preferred Apartment Commu

Retrieved on: 
Monday, February 28, 2022
GLOBE, Ownership, IIF, Brodsky, Intel, USI, Company, Infinite, Kerala Infrastructure Investment Fund Board, The Lord of the Rings: The Two Towers (board game), INTC, Infinite Paths to Infinite Reality, Nasdaq, Indian psychology, SJI, Security (finance)

BALA CYNWYD, Pa., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.

Key Points: 
  • BALA CYNWYD, Pa., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky or Marc Ackerman at 855-576-4847.
  • Tower shareholders will receive $53.00 in cash for each share of Tower stock they hold.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

SOUTH JERSEY INDUSTRIES ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of SJI and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, February 24, 2022
GLOBE, IIF, Squire, P.C, Kerala Infrastructure Investment Fund Board, NYSE, Acquisition, South Jersey Industries, Learning, Telephone, SJI, Property management

On February 24, 2022, SJI announced that it had entered into an agreement to be acquired by IIF in a deal worth approximately $8.1 billion.

Key Points: 
  • On February 24, 2022, SJI announced that it had entered into an agreement to be acquired by IIF in a deal worth approximately $8.1 billion.
  • Pursuant to the merger agreement, SJI shareholders will receive $36 in cash for each share of SJI common stock owned.
  • Bragar Eagel & Squire is concerned that SJIs board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

SJI STOCK ALERT: Halper Sadeh LLP Is Investigating Whether the Sale of South Jersey Industries, Inc. Is Fair to Shareholders

Retrieved on: 
Thursday, February 24, 2022
Legal, Professional Services, Advertising, Kerala Infrastructure Investment Fund Board, IIF, NYSE, South Jersey Industries, Fraud, Sale, SJI, Security (finance)

Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of South Jersey Industries, Inc. (NYSE: SJI) to the Infrastructure Investments Fund (IIF) for $36.00 per share in cash is fair to South Jersey shareholders.

Key Points: 
  • Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of South Jersey Industries, Inc. (NYSE: SJI) to the Infrastructure Investments Fund (IIF) for $36.00 per share in cash is fair to South Jersey shareholders.
  • The investigation concerns whether South Jersey and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for South Jersey shareholders; (2) determine whether IIF is underpaying for South Jersey; and (3) disclose all material information necessary for South Jersey shareholders to adequately assess and value the merger consideration.
  • On behalf of South Jersey shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
  • Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

Media Alert: BrainChip CEO Presents at International Investment Forum 2022

Retrieved on: 
Wednesday, February 16, 2022
Technology, Mobile, Wireless, Semiconductor, Nanotechnology, Networks, Internet, Hardware, Electronic Design Automation, Data Management, ASX, ADR, Learning, IIF, AI, Brain, Central European Time, Carbon, Transport, Technology, Acquisition, OTCQX, Intelligence, Video game console

BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY) the worlds first and only commercial producer of neuromorphic artificial intelligence chips, today announced that CEO Sean Hehir will present to investors and investment groups on the opportunities in edge AI at the 2022 International Investment Forum (IIF), held virtually February 17.

Key Points: 
  • BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY) the worlds first and only commercial producer of neuromorphic artificial intelligence chips, today announced that CEO Sean Hehir will present to investors and investment groups on the opportunities in edge AI at the 2022 International Investment Forum (IIF), held virtually February 17.
  • Fourteen companies were selected to participate, all representing cutting-edge industries such as technology, medical, digital media, commodities/rare earth and materials, crypto, real estate and aerospace.
  • Participating investors can expect to hear far more about BrainChips mission to transform sectors like healthcare, transportation, automotive, and industrial IoT.
  • IIF 2022 takes place live via Zoom beginning at 9:45 a.m. Central European Time (3:45 a.m. Eastern/7:45 p.m. Australia EDT).

DGAP-News: GBC AG: Invitation to the 2nd International Investment Forum (IIF) - [ONLINE] on February 17, 2022 - REGISTER NOW

Retrieved on: 
Tuesday, February 8, 2022
ISIN, LAI, GBC, GAS, META, CET, Biotechnology, ONLINE, IIF, Speaker, Security (finance), Nightclub, Airline, Generic drug

GBC AG: Invitation to the 2nd International Investment Forum (IIF) - [ONLINE] on February 17, 2022 - REGISTER NOW

Key Points: 
  • GBC AG: Invitation to the 2nd International Investment Forum (IIF) - [ONLINE] on February 17, 2022 - REGISTER NOW
    The issuer is solely responsible for the content of this announcement.
  • only a few days until the start of the event - we hereby invite you to attend the 2nd International Investement Forum (IIF) on February 17, 2022 starting at 09:55 am (CET).
  • As a purely digital live event, the International Investment Forum (IIF) offers access to listed companies from the small- and mid-cap segments all over the world with no detours.
  • The Speakers on February 17, 2022 will be board members of listed companies from sectors of commodities, real estate, energy, chip technology, biotechnology, crypto and space.

DGAP-News: GBC AG: Invitation to the 2nd International Investment Forum (IIF) - [ONLINE] on February 17, 2022

Retrieved on: 
Wednesday, January 19, 2022
GBC, Participation, Biotechnology, CET, LAI, ISIN, GAS, ALPHA, META, Speaker, IIF, ONLINE, Security (finance), Airline, Generic drug

GBC AG: Invitation to the 2nd International Investment Forum (IIF) - [ONLINE] on February 17, 2022

Key Points: 
  • GBC AG: Invitation to the 2nd International Investment Forum (IIF) - [ONLINE] on February 17, 2022
    The issuer is solely responsible for the content of this announcement.
  • we hereby invite you to attend the 2nd International Investement Forum (IIF) on February 17, 2022 starting at 09:55 am (CET).
  • As a purely digital live event, the International Investment Forum (IIF) offers access to listed companies from the small- and mid-cap segments all over the world with no detours.
  • The Speakers on February 17, 2022 will be board members of listed companies from sectors of commodities, real estate, energy, chip technology, biotechnology, crypto and space.

DGAP-News: GBC AG: SAVE THE DATE - February 17, 2022 // Invitation to the International Investment Forum (IIF)

Retrieved on: 
Thursday, January 13, 2022
THE, GBC, Foreign direct investment, DATE, CET, Chief executive officer, Central European, IIF, Biotechnology, Renewable energy, Security (finance), Zoom, IIF - International Investment Forum, GBC AG (Co-Organizer), Apaton Finance GmbH (Co-Organizer), IIF - INTERNATIONAL INVESTMENT FORUM, GBC AG (CO-ORGANIZER), APATON FINANCE GMBH (CO-ORGANIZER)

GBC AG: SAVE THE DATE - February 17, 2022 // Invitation to the International Investment Forum (IIF)

Key Points: 
  • GBC AG: SAVE THE DATE - February 17, 2022 // Invitation to the International Investment Forum (IIF)
    The issuer is solely responsible for the content of this announcement.
  • SAVE THE DATE - February 17, 2022
    The 2nd International Investment Forum (IIF) will take place from 9:55 to 20:30 (CET) digitally and via Zoom.
  • The presenting board members offer unique insights and are available live to answer questions from all investor groups.
  • Exact topics and dates at www.ii-forum.com - registration is now open: https://us06web.zoom.us/webinar/register/4016420726067/WN_fM2DLtC_S7eMzH...
    About IIF - International Investment Forum:
    IIF - International Investment Forum will take place on February 17, 2022.